Orally Disintegrating Tablets Market Analysis GrowthODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia difficulty in swallowing or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
Buy Now and 20% OFF on this Report
Get More Information about this Report @ [URL]https://www.planetmarketreports.com/reports/global-orally-disintegrating-tablets-market-10393[/URL]
Scope of the Report:
This report focuses on the Orally Disintegrating Tablets in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of Orally Disintegrating Tablet includes Anti-Psychotics Drug, Anti-Epileptics Drug and others, and the proportion of Anti-Psychotics Drug in 2017 is about 16.6%, Anti-Psychotics drug class will be the reigning segment in terms of market revenue share throughout the forecast period, anticipated to hold about 20.3% revenue share of the global market by 2025 end. With a noteworthy 15.7% CAGR, this segment will retain its supremacy over other drug class segments during the eight-year period.
Under by Disease Indication, the global market is segmented into Central Nervous System CNS Diseases, Gastrointestinal GI Diseases, Cardiovascular CVS Diseases and Others. CNS Diseases segment will hold maximum revenue share in the global market, and the consumption proportion is about 53.4% in 2017. and forecasts indicate a 57.2% market share for this segment by the end of the forecast period in 2025.
North America is the largest consumption place, with a consumption market share nearly 40.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 31.6%, China is also an important sales region for the Orally Disintegrating Tablet.
The worldwide market for Orally Disintegrating Tablets is expected to grow at a CAGR of roughly $$% over the next five years, will reach $$ million US$ in 2023, from $$ million US$ in 2017, according to a new PMR study.
Market Segment by Manufacturers, this report covers
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Market Segment by Regions, regional analysis covers
North America United States, Canada and Mexico
Europe Germany, France, UK, Russia and Italy
Asia-Pacific China, Japan, Korea, India and Southeast Asia
South America Brazil, Argentina, Colombia etc.
Middle East and Africa Saudi Arabia, UAE, Egypt, Nigeria and South Africa
Market Segment by Type, covers
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Market Segment by Applications, can be divided into
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
Get a Free Sample Copy of this Report @ [URL]https://www.planetmarketreports.com/report-sample/global-orally-disintegrating-tablets-market-10393[/URL]